News for AMAG Pharmaceuticals, Inc. (AMAG)

Dr. Steve Caffé is an accomplished industry executive with over 25 years of expertise in global product development and regulatory affairs...

SAN MATEO, Calif., Aug. 01, 2024 (GLOBE NEWSWIRE) -- Sagimet Biosciences Inc. (Sagimet, Nasdaq: SGMT), a clinical-stage biopharmaceutical company...

AlloVir ends lease early, pays $7 million termination fee

BRISBANE, Calif., Jan. 08, 2024 -- Vera Therapeutics, Inc. , a late clinical-stage biotechnology company developing and commercializing transformative treatments for patients with serious...

The dynamics of the iron deficiency anemia market are anticipated to change in the coming years owing to the improvement in the research and development...

- Topline data from proof-of-concept study of VRDN-001 in patients with chronic thyroid eye disease (TED) are expected in June/July 2023 - - Selection...

WALTHAM, Mass., April 12, 2023 (GLOBE NEWSWIRE) -- Viridian Therapeutics, Inc. (NASDAQ: VRDN), a biopharmaceutical company focused on discovering and...

The FDA has announced Makena and its generics are no longer approved and cannot lawfully be distributed in interstate commerce. The drug that had been approved under the accelerated approval pathway was used to reduce the risk of preterm birth in women pregnant with one baby who have a history of spontaneous preterm birth.

An increase in the number of women experiencing painful coitus is anticipated to drive the global dyspareunia treatment market in the forthcoming years...

/PRNewswire/ -- The "Intravenous Iron Drugs Market- Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028: Segmented By Application...

EWING, N.J., Feb. 17, 2021 (GLOBE NEWSWIRE) -- Antares Pharma, Inc. (NASDAQ:ATRS) ("the Company"), a pharmaceutical technology company, today announced that ...